Categories: News

Arvind Remedies’ Q3 net up 46% at Rs 19 cr


New Delhi February 18, 2014:- Branded and generic pharmaceutical products manufacturer
 posted 46% rise in its  at Rs 19 crore for the quarter ended December 31, 2013 as compared to Rs 13 crore in the corresponding period last year.

 of the company rose 29% to Rs 233 crore for December quarter as against Rs 180 crore in the same quarter of the previous year.-Business Standard

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

2 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

3 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

3 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

4 days ago